Skip to content

Comparison of Telemedical and Conventional Treatment of Hypertension

Treatment of Hypertension Using Telemedical Home Blood Pressure Measurements

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02531347
Enrollment
375
Registered
2015-08-24
Start date
2011-03-31
Completion date
2014-12-31
Last updated
2015-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The purpose of the study is to compare antihypertensive treatment based on either conventional blood pressure measurements or telemedical home blood pressure measurements. Hypothesis is that telemedical treatment of hypertension is more effective in lowering blood pressure, is more cost-effective and provides better quality of life.

Interventions

BEHAVIORALConventional blood pressure monitoring

Sponsors

Erling Bjerregaard Pedersen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 55 to 64 years * Registered address in the Municipality of Holstebro * Enrolment at a practice of one of the general practitioners who had agreed to participate in the study * Telemedical home blood pressure measurement with ≥12 measurements on day 2 and 3. * Elevated home blood pressure ≥135/85 (if diagnosed diabetes, chronic kidney disease or prior stroke ≥130/80) * Hypertension confirmed by daytime ambulatory blood pressure ≥135/85 (if diagnosed diabetes, chronic kidney disease or prior stroke ≥130/80) * ECG verified sinus rhythm

Exclusion criteria

* Unwillingness to participate * Normotension * Withdrawal of consent to participate

Design outcomes

Primary

MeasureTime frameDescription
Blood pressure reduction3 monthDifference in daytime ambulatory blood pressure from baseline to followup between intervention and control group

Secondary

MeasureTime frame
Number of patients reaching target blood pressure3 month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026